Global Medical Financials
GMRE Stock | USD 9.14 0.03 0.33% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.022 | 0.0232 |
|
|
The financial analysis of Global Medical is a critical element in measuring its lifeblood. Investors should not minimize Global Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Global | Select Account or Indicator |
Understanding current and past Global Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Global Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Global Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Global Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Global Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Global Medical's management manipulating its earnings.
Global Medical Stock Summary
Global Medical competes with Healthpeak Properties, Community Healthcare, Welltower, and LTC Properties. Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share. Global Medical operates under REITHealthcare Facilities classification in the United States and is traded on New York Stock Exchange. It employs 26 people.Specialization | Real Estate, Equity Real Estate Investment Trusts (REITs) |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US37954A2042 |
CUSIP | 37954A204 |
Location | Maryland; U.S.A |
Business Address | 7373 Wisconsin Avenue, |
Sector | Diversified REITs |
Industry | Real Estate |
Benchmark | Dow Jones Industrial |
Website | www.globalmedicalreit.com |
Phone | 202 524 6851 |
Currency | USD - US Dollar |
Global Medical Key Financial Ratios
There are many critical financial ratios that Global Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Global Medical REIT reports annually and quarterly.Return On Equity | 0.0094 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.25 % | ||||
Price To Sales | 4.36 X | ||||
Revenue | 156.65 M |
Global Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 884.9M | 1.1B | 1.3B | 1.4B | 1.3B | 1.3B | |
Other Current Liab | 12.7M | 12.5M | 15.7M | 11.4M | 601.1M | 631.1M | |
Net Debt | 383.4M | 581.1M | 564.5M | 690.1M | 616.8M | 647.6M | |
Retained Earnings | (71.4M) | (116.8M) | (157.0M) | (198.7M) | (239.0M) | (227.0M) | |
Cash | 2.8M | 5.5M | 7.2M | 4.0M | 7.4M | 5.5M | |
Other Current Assets | (29.8M) | (41.5M) | (50.3M) | 18.3M | (41.1M) | (39.1M) | |
Total Liab | 424.6M | 643.1M | 625.9M | 744.2M | 661.9M | 695.0M | |
Total Current Assets | 15.6M | 21.3M | 24.9M | 30.5M | 14.4M | 13.4M | |
Common Stock | 44K | 49K | 65K | 66K | 75.9K | 79.7K | |
Net Tangible Assets | 313.9M | 363.9M | 541.9M | 552.1M | 634.9M | 666.7M | |
Accounts Payable | 5.1M | 7.3M | 10.3M | 13.8M | 12.8M | 13.4M | |
Capital Surpluse | 433.3M | 504.8M | 711.4M | 722.0M | 830.3M | 871.8M | |
Other Liab | 11.2M | 12.6M | 20.4M | 17.5M | 20.1M | 21.1M | |
Other Assets | 18.2M | 985.7M | 1.1B | 1.2B | (1K) | (950.0) | |
Long Term Debt | 386.2M | 83.0M | 57.2M | 57.7M | 25.9M | 24.6M | |
Net Receivables | 5.0M | 5.7M | 6.2M | 8.2M | 33.7M | 35.4M | |
Long Term Debt Total | 386.2M | 83.0M | 65.0M | 57.7M | 66.3M | 63.0M | |
Short Long Term Debt | 6.5M | 521.6M | 514.6M | 636.4M | 585.3M | 614.6M | |
Short Term Debt | 347.5M | 521.6M | 514.6M | 636.4M | 405K | 384.8K | |
Good Will | 29.3M | 36.3M | 59.1M | 5.9M | 5.3M | 5.0M |
Global Medical Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 17.5M | 18.7M | 19.7M | 25.2M | 46.5M | 48.8M | |
Operating Income | 27.3M | 16.5M | 37.1M | 38.8M | 53.5M | 56.2M | |
Ebit | 27.3M | (24.6M) | 5.0M | (2.3M) | 8.6M | 9.0M | |
Ebitda | 52.0M | 52.9M | 84.0M | 96.5M | 111.7M | 117.3M | |
Income Before Tax | 9.6M | (2.5M) | 18.3M | 20.0M | 21.7M | 22.8M | |
Net Income | (8.2M) | (20.6M) | (2.1M) | (5.2M) | 20.6M | 21.6M | |
Income Tax Expense | 17.8M | 18.1M | 20.4M | 25.2M | 1.1M | 1.1M | |
Total Revenue | 70.7M | 93.7M | 115.9M | 137.3M | 156.7M | 164.5M | |
Gross Profit | 64.8M | 82.9M | 100.4M | 112.1M | 70.4M | 56.9M | |
Cost Of Revenue | 6.0M | 10.9M | 15.5M | 25.2M | 86.2M | 90.5M | |
Non Recurring | 17.7M | 19.0M | 19.8M | 25.6M | 29.4M | 30.9M | |
Minority Interest | 30.1M | (574K) | (720K) | 854K | (1.2M) | (1.2M) | |
Net Interest Income | (17.5M) | (18.7M) | (19.7M) | (25.2M) | (32.0M) | (30.4M) |
Global Medical Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 2.3M | 3.6M | 2.0M | 1.7M | (14.9M) | (14.1M) | |
Free Cash Flow | (220.4M) | (184.3M) | (132.7M) | (79.7M) | 58.4M | 61.3M | |
Other Non Cash Items | 1.8M | 1.6M | 2.2M | (4.1M) | 113.3M | 118.9M | |
Capital Expenditures | 256.8M | 218.8M | 201.7M | 156.2M | 10.0M | 9.5M | |
Net Income | 9.6M | (2.5M) | 18.3M | 20.0M | 20.6M | 21.6M | |
End Period Cash Flow | 7.2M | 10.8M | 12.8M | 14.5M | 7.4M | 8.4M | |
Investments | (1.8M) | (1.1M) | (9.5M) | (4.3M) | 69.3M | 72.8M | |
Net Borrowings | 69.7M | 187.1M | (10.6M) | 120.0M | 138.0M | 85.3M | |
Depreciation | 25.5M | 36.8M | 47.3M | 57.7M | 58.1M | 61.0M | |
Dividends Paid | 35.0M | 45.8M | 58.3M | 64.2M | 64.8M | 34.4M | |
Change To Netincome | 3.7M | 5.4M | 5.7M | (1.6M) | (1.8M) | (1.7M) | |
Change To Inventory | 79K | 584K | (1.7M) | 200K | 180K | 189K | |
Change Receivables | (2.1M) | (1.6M) | (657K) | (3.0M) | (2.7M) | (2.5M) |
Global Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Global Medical's current stock value. Our valuation model uses many indicators to compare Global Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Global Medical competition to find correlations between indicators driving Global Medical's intrinsic value. More Info.Global Medical REIT is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers reporting about 1.85 of Return On Asset per Return On Equity. At present, Global Medical's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Global Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Global Medical REIT Systematic Risk
Global Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Global Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty-two with a total number of output elements of nine. The Beta measures systematic risk based on how returns on Global Medical REIT correlated with the market. If Beta is less than 0 Global Medical generally moves in the opposite direction as compared to the market. If Global Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Global Medical REIT is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Global Medical is generally in the same direction as the market. If Beta > 1 Global Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Global Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Global Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Global Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Global Medical September 7, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Global Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Global Medical REIT. We use our internally-developed statistical techniques to arrive at the intrinsic value of Global Medical REIT based on widely used predictive technical indicators. In general, we focus on analyzing Global Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Global Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 1.65 | |||
Information Ratio | (0.02) | |||
Maximum Drawdown | 8.8 | |||
Value At Risk | (2.54) | |||
Potential Upside | 2.28 |
Complementary Tools for Global Stock analysis
When running Global Medical's price analysis, check to measure Global Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Medical is operating at the current time. Most of Global Medical's value examination focuses on studying past and present price action to predict the probability of Global Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Medical's price. Additionally, you may evaluate how the addition of Global Medical to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |